Use this Bactrim pediatric dose calculator to dose TMP-SMX, co-trimoxazole, or Septra by the trimethoprim component, then convert the plan to suspension mL or tablet strengths.
For children 2 months and older: Bactrim (sulfamethoxazole-trimethoprim) for bladder or ear infections is trimethoprim (TMP) 8 mg/kg per day, as 4 mg/kg every 12 hours, max 160 mg TMP per dose (label). Doses are set by the TMP part. Each 5 mL has TMP 40 mg and SMX 200 mg, so the SMX amount is always 5 times the TMP: for example, 10 mL = TMP 80 mg + SMX 400 mg. If a prescription gives the dose in mg, check whether it is the TMP or the SMX number.
| Weight (lb) | Weight (kg) | Bladder or ear infection: TMP 4 mg/kg every 12 hoursmL of 200 mg/40 mg per 5 mL suspension per dose (mg TMP it contains) |
|---|---|---|
| 15check age: never under 2 months | 6.8 | 3.4 mL (27.2 mg TMP) |
| 20 | 9.1 | 4.5 mL (36 mg TMP) |
| 25 | 11.3 | 5.5 mL (44 mg TMP) |
| 30 | 13.6 | 7 mL (56 mg TMP) |
| 35 | 15.9 | 8 mL (64 mg TMP) |
| 40 | 18.1 | 9 mL (72 mg TMP) |
| 45 | 20.4 | 10 mL (80 mg TMP) |
| 50 | 22.7 | 11.5 mL (92 mg TMP) |
| 55 | 24.9 | 12.5 mL (100 mg TMP) |
| 60 | 27.2 | 13.5 mL (108 mg TMP) |
| 65 | 29.5 | 14.5 mL (116 mg TMP) |
| 70 | 31.8 | 16 mL (128 mg TMP) |
| 75 | 34 | 17 mL (136 mg TMP) |
| 80 | 36.3 | 18 mL (144 mg TMP) |
| 85 | 38.6 | 19.5 mL (156 mg TMP) |

Bactrim TMP component
Bactrim and TMP-SMX plans should be calculated from the trimethoprim component, then converted into 200/40 mg per 5 mL liquid or tablet strengths.
mL per dose = prescribed trimethoprim mg per dose / (40 mg trimethoprim / 5 mL), which equals TMP mg per dose / 8 mg per mL.
For an 80 mg trimethoprim dose using 200/40 mg per 5 mL liquid, the measured volume is 10 mL per dose.
Practical dosing guide
Use this page to dose TMP-SMX by the trimethoprim component, match the right liquid or tablet strength, and double-check the skin-rash and hydration cautions before starting.
Bactrim (sulfamethoxazole-trimethoprim, TMP-SMX, co-trimoxazole, Septra) treats UTIs, skin infections, and other bacterial illnesses. The Bactrim pediatric dose calculator converts weight-based TMP-SMX dosing based on the trimethoprim component into practical doses.
Choose SMX-TMP for purulent skin and soft-tissue infections when MRSA is suspected, but pair with beta-lactam therapy if group A streptococcal coverage is needed.
For PJP prophylaxis in children with HIV, solid organ transplants, or oncology diagnoses, low-dose regimens significantly reduce morbidity—ensure adherence and lab monitoring.
Sulfamethoxazole-trimethoprim (TMP-SMX) is useful in pediatrics when susceptibility is likely or documented, especially for select urinary, skin, and opportunistic infections where narrower options are limited.
Community-acquired MRSA skin and soft tissue infections: Use when MRSA is suspected or confirmed; combine with drainage when abscess present.
Nocardiosis: Often requires prolonged therapy and specialist management.
Sulfamethoxazole-trimethoprim has one of the highest risks for severe cutaneous adverse reactions among all medications, with a relative risk of 160-172 for Stevens-Johnson syndrome. While generally effective for bacterial infections, the drug carries significant risks in pediatric patients including hypersensitivity reactions (1-3% in healthy children), hyperkalemia, and bone marrow suppression. It is contraindicated in infants under 2 months due to toxicity concerns. Immediate discontinuation is required at the first sign of any rash, as this may herald life-threatening reactions.
Sulfamethoxazole-trimethoprim (SMX-TMP) works because the two components interrupt the same bacterial pathway at different points. Sulfamethoxazole blocks dihydropteroate synthase and limits upstream folate precursor formation, while trimethoprim blocks dihydrofolate reductase and prevents conversion to active tetrahydrofolate. With both steps constrained, susceptible bacteria cannot maintain nucleotide production needed for replication and repair. In practice, this is why the combination performs better than either agent alone for selected infections. The fixed 5:1 SMX:TMP formulation is built to produce clinically useful paired concentrations rather than treating each ingredient as an independent monotherapy. Host cells are less affected because humans rely on dietary folate, but clinically relevant off-target effects still occur, including antifolate-related cytopenias and trimethoprim-associated potassium elevation in higher-risk patients.
SMX-TMP treats a range of bacterial infections, including urinary tract infections, certain gastrointestinal infections (e.g., traveler's diarrhea, Shigella), and skin infections caused by MRSA. It’s also used for rare but serious infections like *Pneumocystis jirovecii* pneumonia (PCP) in immunocompromised children and for *Nocardia* infections. While not a first-line antibiotic for most respiratory infections, it is used when there are resistant organisms or allergies to other antibiotics. Providers typically choose SMX-TMP for targeted reasons due to its side effect profile.
The most common side effects include mild rash, nausea, vomiting, and loss of appetite. Some children experience diarrhea or sun sensitivity. Rare but serious side effects include severe skin reactions like Stevens-Johnson syndrome and blood disorders (such as low platelets or white blood cells). If your child develops any rash, mouth sores, signs of bruising, or acts unusually tired, call your doctor right away. Most children tolerate the medication well, especially when used short term and monitored closely.
SMX-TMP is given by mouth as a liquid or tablet, usually twice daily. The liquid should be shaken well before each dose and measured with an accurate dosing device like an oral syringe. It can be given with or without food – but giving it with a small snack or drink may help reduce nausea. Encourage your child to drink plenty of fluids while on the medication. Always follow the dosing schedule exactly and finish the full course unless your doctor advises otherwise.
Always let your healthcare provider know about any medications your child takes, including over-the-counter drugs and supplements. SMX-TMP can interact with medications like methotrexate, phenytoin, diuretics, or ACE inhibitors, increasing the risk of side effects like kidney problems or high potassium. Your provider will evaluate for interactions before prescribing it. Do not give any new medications or supplements during the course unless cleared by the doctor.
No. SMX-TMP should not be used in infants younger than 2 months due to the risk of kernicterus, a serious neurological condition caused by high bilirubin levels. In older infants and children, it is generally safe when dosed appropriately, but always under medical supervision. If your child is younger than 2 months and needs treatment, the provider will select an alternative antibiotic.
Yes. Bactrim is a brand name for sulfamethoxazole-trimethoprim (TMP-SMX). Dosing is based on the trimethoprim component in mg/kg/day.
Use the trimethoprim component in mg/kg/day, not the sulfamethoxazole number. The calculator converts that TMP-based target into a practical liquid or tablet regimen for your child’s weight.
aap-uti-2011
dailymed-bactrim-setid-f59d0c04
nih-pcp-children-2024
cdc-shigella-2024
aap-aom-2013
idsa-ssti-2014